Rezolute (RZLT) Other Accumulated Expenses (2014 - 2023)

Rezolute (RZLT) reported Other Accumulated Expenses of $1.1 million for Q1 2023, up 46.73% on a YoY basis from $764000.0 in Q1 2022, and up 4.67% sequentially from $1.1 million in Q4 2022.

Rezolute (RZLT) Other Accumulated Expenses (2014 - 2023) Analysis & Trends

Rezolute (RZLT) has 10 years of Other Accumulated Expenses data on file, last reported at $1.1 million in Q1 2023.

  • For the quarter ending Q1 2023, Other Accumulated Expenses rose 46.73% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2023 stood at $1.1 million (up 46.73% YoY), and the FY2022 full-year result was $243000.0, changed 0.41% from the prior year.
  • Other Accumulated Expenses rose to $1.1 million in Q1 2023, from $1.1 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $1.1 million in Q1 2023 to a low of $122000.0 in Q3 2022.
  • A 5-year average of $486357.1 and a median of $388500.0 in 2020 frame the typical range for Other Accumulated Expenses.
  • Across the five-year window, Other Accumulated Expenses jumped 361.4% in 2019 and tumbled 82.03% in 2022, its largest moves.
  • Tracing RZLT's Other Accumulated Expenses over 5 years: stood at $641000.0 in 2019, then sank by 53.2% to $300000.0 in 2020, then surged by 59.0% to $477000.0 in 2021, then jumped by 124.53% to $1.1 million in 2022, then gained by 4.67% to $1.1 million in 2023.
  • Business Quant data shows RZLT's Other Accumulated Expenses at $1.1 million in Q1 2023, $1.1 million in Q4 2022, and $122000.0 in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,042.03 Bn 67,041.74 Bn -
2 Nanobiotix 1,908.00 Bn 1,907.94 Bn -
3 Akari Therapeutics 959.56 Bn 959.56 Bn -
4 BeOne Medicines 472.89 Bn 468.10 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.12 Bn 114.87 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.04 Bn 61.29 Bn 3.31 Bn
7 Belite Bio 62.68 Bn 62.68 Bn -
8 Argenx Se 55.90 Bn 50.72 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.47 Bn 34.46 Bn 959.66 Mn
10 Rezolute 515.52 Mn 515.52 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2023 1.12 Mn
Dec 31, 2022 1.07 Mn
Sep 30, 2022 122,000.00
Jun 30, 2022 243,000.00
Mar 31, 2022 764,000.00
Dec 31, 2021 477,000.00
Sep 30, 2021 679,000.00
Jun 30, 2021 242,000.00
Sep 30, 2020 300,000.00
Jun 30, 2020 180,000.00
Mar 31, 2020 284,000.00
Dec 31, 2019 641,000.00
Sep 30, 2019 159,000.00
Jun 30, 2019 526,000.00
Sep 30, 2018 132,922.00
Jun 30, 2018 114,000.00
Mar 31, 2018 121,705.00
Dec 31, 2017 116,234.00
Sep 30, 2017 110,765.00
Jun 30, 2017 105,295.00